GlassScriptPhysician profile
Suk Ki Kim
NPI 1477557270
$1,414.20
in general payments reported to CMS, 2019-2025
19 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $126 · 2021: $26.29 · 2022: $268 · 2023: $357 · 2024: $96.10 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $321.83 | 2020-2024 | Senza |
| Medtronic, INC. | $209.39 | 2022-2025 | Intellis Adaptivestim |
| Globus Medical, INC. | $191.51 | 2025 | Senza, Omnia |
| Grt US Holding, INC. | $191.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $170.09 | 2019-2025 | Xtampza, Belbuca |
| Valinor Pharma, LLC | $35.60 | 2025 | Movantik |
| Boston Scientific Corporation | $34.26 | 2019-2021 | |
| Vertos Medical, INC. | $31.70 | 2019 | |
| Medtronic USA, INC. | $31.13 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $28.86 | 2019 | |
| Scilex Pharmaceuticals INC. | $28.68 | 2023 | Ztlido |
| Pfizer INC. | $23.69 | 2019 | |
| Lilly USA, LLC | $19.29 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.17 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $18.48 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $17.01 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.95 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suk Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.